Filippo Ceccato

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016

Ann McCormack, Olaf M. Dekkers, Stephan Petersenn et al. · European Journal of Endocrinology · 2018 · 269 citations · Full text

Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study

Timo Deutschbein, Giuseppe Reimondo, Guido Di Dalmazi et al. · The Lancet Diabetes & Endocrinology · 2022 · 162 citations · Full text

Adrenal Gland, Adrenal Incidentalomas, Clinical Epidemiology +5

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

Marco Losa, Fausto Bogazzi, Filippo Ceccato et al. · Journal of Neuro-Oncology · 2015 · 132 citations

Pituitary Gland, Medicine, Temozolomide Therapy +3

Combination therapy for Cushing’s disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?

Mattia Barbot, Nora Albiger, Filippo Ceccato et al. · Pituitary · 2013 · 113 citations

Clinical Therapeutic, Pharmacology, Treatment Option +4

Salivary cortisol and cortisone by LC–MS/MS: validation, reference intervals and diagnostic accuracy in Cushing's syndrome

Giorgia Antonelli, Filippo Ceccato, Carlo Alberto Artusi et al. · Clinica Chimica Acta · 2015 · 105 citations

Reference Intervals, Psychiatry, Multiple Sclerosis +4